Sofía de la Villa-Martínez

13PUBLICATIONS
53CO-AUTHORS
Proteomics and metabolomicsCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyMedical infection agents (incl. prions)Clinical microbiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 30, 2026
Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

|Mar 01, 2026
Oritavancin in Complicated Bloodstream Infections and Endocarditis in Spain and Italy (ORIBAC Study): A Retrospective Multicenter Observational Study.

Antonio Vena, Laura Mezzogori, Matteo Bassetti

|Dec 18, 2025
Analysis of Clinical Subphenotypes in Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the MRSA-GEIRAS-SEIMC Study.

Sofía De La Villa, Nuria Fernández-Hidalgo, Francesc Escrihuela-Vidal

|Jun 27, 2024
Do High Doses of Multiple Antibiotics Loaded into Bone Cement Spacers Improve the Success Rate in Staphylococcal Periprosthetic Joint Infection When Rifampicin Cannot Be Employed?

Lourdes Prats-Peinado, Tanya Fernández-Fernández, Miguel Márquez-Gómez

|Jun 16, 2023
Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY).

Sofía De La Villa, Carlos Sánchez-Carrillo, Celia Sánchez-Martínez

|Mar 23, 2023
Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS.

Maricela Valerio, Cristina Veintimilla, Carmen Rodríguez

Pageof 3

Frequent Collaborators

8 joint publications

Patricia Muñoz

3 joint publications

Maricela Valerio

2 joint publications

Ana Álvarez-Uría

2 joint publications

Manuel Martínez-Sellés